Video Library Announcements COVID-19 Update for Advisors and Representatives

COVID-19 Update for Advisors and Representatives

An update to advisors and representatives on ExchangeRight’s performance and outlook during the COVID-19 pandemic. Watch the video to hear Warren’s advice to wealth advisors and registered representatives about how to acquire and maintain clients during economically uncertain times.
Share
Length
04:17
Series
Announcements

Other Videos in Announcements Series

We are proud to announce the full subscription of Net-Leased All-Cash 14 DST, adding to the growing acquisition pipeline for ExchangeRight’s Essential Income REIT. The $23.3 million debt-free portfolio of net-leased real estate, backed by tenants operating in necessity-based industries, provides investors with monthly distributions at a current rate of 5.20% covered entirely by in-place lease revenues. Net-Leased All-Cash 14 DST is a closed offering and is not accepting new investors.

We are pleased to announce the full subscription of Essential Income 4 DST. This full subscription is part of the company’s Essential Income DST series, designed to provide investors with accelerated access to the Essential Income REIT via a tax-deferred Section 721 exchange after a two-year hold period. Essential Income 4 DST is a closed offering and is not accepting new investors.

ExchangeRight's Essential Income REIT (the "EIR") is focused on investing in properties net-leased to recession-resilient tenants primarily with investment-grade credit that are successfully operating in the necessity-based retail and healthcare industries. Class ER Shares are structured to provide investors with the REIT’s tax-efficient monthly income and long-term growth potential, a year-one bonus distribution, and participation in ExchangeRight’s performance fee after a targeted five-year hold. Existing ER share investors who invested shortly after this new share class was launched have enjoyed year-one tax-equivalent yields ranging between 13-14% for 2024. Past performance does not guarantee future results.